Literature DB >> 28239840

Melasma: systematic review of the systemic treatments.

Linghong Linda Zhou1, Akerke Baibergenova2.   

Abstract

Currently available treatment options for melasma include prevention of UV radiation, topical lightening agents, chemical peels, and light-based and laser therapies. However, none have shown effective and sustained results, with incomplete clearance and frequent recurrences. There has been increasing interest recently in oral medications and dietary supplements in improving melasma. We sought to evaluate the efficacy and safety/tolerability of oral medications and dietary supplements for the treatment of melasma. Multiple databases were systematically searched for randomized clinical trials (RCTs) evaluating the use of oral medication for treatment of melasma alone or in combination with other treatments. A total of eight RCTs met inclusion criteria. Oral medications and dietary supplements evaluated include tranexamic acid, Polypodium leucotomos extract, beta-carotenoid, melatonin, and procyanidin. These agents appear to have a beneficial effect on melasma improvement. In conclusion, oral medications have a role in melasma treatment and have been shown to be efficacious and tolerable with a minimal number and severity of adverse events. Therefore, dermatologists should keep oral medications and dietary supplements in their armamentarium for the treatment of melasma.
© 2017 The International Society of Dermatology.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28239840     DOI: 10.1111/ijd.13578

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  3 in total

Review 1.  Dermatologic Applications of Polypodium leucotomos: A Literature Review.

Authors:  Kelly Segars; Victoria McCarver; Richard A Miller
Journal:  J Clin Aesthet Dermatol       Date:  2021-02-01

2.  Evaluation of Therapeutic Efficacy and Safety of Tranexamic Acid Local Infiltration in Combination with Topical 4% Hydroquinone Cream Compared to Topical 4% Hydroquinone Cream Alone in Patients with Melasma: A Split-Face Study.

Authors:  Zohreh Tehranchinia; Bita Saghi; Hoda Rahimi
Journal:  Dermatol Res Pract       Date:  2018-07-02

3.  Current evidence to support the therapeutic potential of flavonoids in oxidative stress-related dermatoses.

Authors:  Dehai Xian; Menglu Guo; Jixiang Xu; Yang Yang; Yangmeng Zhao; Jianqiao Zhong
Journal:  Redox Rep       Date:  2021-12       Impact factor: 4.412

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.